Murielle Reboul

543 total citations
18 papers, 399 citations indexed

About

Murielle Reboul is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Murielle Reboul has authored 18 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Murielle Reboul's work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Murielle Reboul is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers) and T-cell and B-cell Immunology (5 papers). Murielle Reboul collaborates with scholars based in France, Czechia and United Kingdom. Murielle Reboul's co-authors include Marika Pla, Christine Chomienne, Rose Ann Padua, Silvia Martinozzi, Terry J. Gaymes, Stéphanie Beurlet, Nicholas Lea, Nicola Brady, Nader Omidvar and Ghulam J. Mufti and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Murielle Reboul

18 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murielle Reboul France 9 256 101 99 62 45 18 399
Hamlata Dewchand United Kingdom 12 313 1.2× 153 1.5× 44 0.4× 61 1.0× 7 0.2× 14 544
Yasukazu Sagawa Japan 7 99 0.4× 113 1.1× 52 0.5× 45 0.7× 37 0.8× 10 358
P. G. Natali United States 9 181 0.7× 110 1.1× 20 0.2× 15 0.2× 16 0.4× 19 337
LJ Guilbert Canada 9 192 0.8× 75 0.7× 115 1.2× 14 0.2× 5 0.1× 12 351
M.C. Magli Netherlands 4 93 0.4× 122 1.2× 178 1.8× 60 1.0× 40 0.9× 7 417
Steven C. Braddy United States 7 385 1.5× 119 1.2× 47 0.5× 20 0.3× 5 0.1× 9 494
Astrid Menning Germany 7 339 1.3× 79 0.8× 16 0.2× 18 0.3× 48 1.1× 8 426
Lanzhen Liu United States 5 333 1.3× 69 0.7× 79 0.8× 13 0.2× 12 0.3× 8 522
M Barbaresi Italy 6 1.0k 3.9× 36 0.4× 138 1.4× 16 0.3× 14 0.3× 9 1.0k
Jack Treml United States 10 284 1.1× 113 1.1× 15 0.2× 20 0.3× 9 0.2× 14 434

Countries citing papers authored by Murielle Reboul

Since Specialization
Citations

This map shows the geographic impact of Murielle Reboul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murielle Reboul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murielle Reboul more than expected).

Fields of papers citing papers by Murielle Reboul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murielle Reboul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murielle Reboul. The network helps show where Murielle Reboul may publish in the future.

Co-authorship network of co-authors of Murielle Reboul

This figure shows the co-authorship network connecting the top 25 collaborators of Murielle Reboul. A scholar is included among the top collaborators of Murielle Reboul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murielle Reboul. Murielle Reboul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pokorná, Kateřina, Martine Chopin, N Balitrand, et al.. (2012). Tracking the extramedullary PML-RARα-positive cell reservoirs in a preclinical model: Biomarker of long-term drug efficacy. Molecular and Cellular Probes. 27(1). 1–5. 4 indexed citations
3.
Rassool, Feyruz V., Terry J. Gaymes, Nader Omidvar, et al.. (2007). Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia?. Cancer Research. 67(18). 8762–8771. 130 indexed citations
4.
Fiorentino, Susana, Martine Chopin, Hélène Dastot, et al.. (2005). Disruption of T cell regulatory pathways is necessary for immunotherapeutic cure of T cell acute lymphoblastic leukemia in mice.. PubMed. 16(4). 300–8. 4 indexed citations
5.
Menier, Catherine, Berta Sáez, Václav Hořejšı́, et al.. (2003). Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Human Immunology. 64(3). 315–326. 133 indexed citations
6.
Ulbrecht, Matthias, Valeska Hofmeister, Joachim W. Ellwart, et al.. (2003). HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Human Immunology. 64(2). 231–237. 20 indexed citations
7.
Reboul, Murielle, et al.. (1998). Strong Alloantigenicity of the α-Helices Residues of the MHC Class I Molecule. The Journal of Immunology. 161(1). 148–153. 8 indexed citations
8.
Reboul, Murielle, et al.. (1998). Strong alloantigenicity of the alpha-helices residues of the MHC class I molecule.. PubMed. 161(1). 148–53. 8 indexed citations
9.
Reboul, Murielle, et al.. (1996). Alloreactive monoclonal antibodies select Kd molecules with different peptide profiles. The Journal of Immunology. 157(6). 2455–2461. 16 indexed citations
10.
Frangoulis, Bernard, Murielle Reboul, Anna Rocca, & Marika Pla. (1993). Cross‐reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA‐B27 and H‐2Kk) revealed by xenoreactive T lymphocytes. European Journal of Immunology. 23(2). 338–342. 5 indexed citations
11.
Reboul, Murielle, Bernard Frangoulis, Anna Rocca, Laurent Degos, & Marika Pla. (1991). Recognition of HLA-B27 by mouse cytotoxic T-cell clones: a transgenic mouse. Immunogenetics. 34(3). 196–200. 4 indexed citations
12.
Mourik, Peter van, et al.. (1986). ANTI‐MHC IMMUNITY DETECTED PRIOR TO INTENTIONAL ALLOIMMUNIZATION. International Journal of Immunogenetics. 13(2-3). 287–298. 5 indexed citations
13.
Reboul, Murielle, et al.. (1981). [Diffuse form of Bazex's paraneoplastic acrokeratosis disclosing a recurrence and metastases of a previously treated cancer of the epiglottis].. PubMed. 108(11). 885–8. 5 indexed citations
14.
Tchen, Paul, E Bois, N Feingold, et al.. (1978). Histocompatibility Antigens in two American Indian Tribes of French Guiana. Tissue Antigens. 11(3). 315–319. 12 indexed citations
15.
Colombani, M, et al.. (1977). DETECTION OF HUMAN B LYMPHOCYTE ALLOANTIGENS BY COMPLEMENT FIXATION1. Transplantation. 24(3). 230–233. 15 indexed citations
16.
Schmid, M, Hélène Dastot, Murielle Reboul, et al.. (1975). HL–A Phenotyping in an Indonesian Population. Tissue Antigens. 5(2). 80–84. 5 indexed citations
17.
Colombani, J, André Chaventré, Albert Jacquard, et al.. (1975). The HL–A Gene Structure of Twareg Populations. II. TheKelDiniq. Tissue Antigens. 5(1). 3–11. 2 indexed citations
18.
Schmid, M, et al.. (1974). Anti‐HL‐A Immunization after Repeated Haemodialysis in Relation to Patients’ HL‐A Types. Tissue Antigens. 4(1). 130–135. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026